Application of nanoparticles on diagnosis and therapy in gliomas

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Hernández Pedro, Norma Y ^a   Rangel López, Edgar ^a   Magaña Maldonado, Roxana ^a   De La Cruz, Verónica Pérez ^a   Del Angel, Abel Santamaría ^a   Pineda, Benjamín ^a   Sotelo, Julio ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CURCUMIN; DENDRIMER; FLUORODEOXYGLUCOSE F 18; MAGNETIC NANOPARTICLE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; NANOCRYSTAL; NANOPARTICLE; NANOSHELL; NANOTUBE; PACLITAXEL; POLYASPARTIC ACID; QUANTUM DOT; SOLID LIPID NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; ANTIBODY; DIAGNOSTIC AGENT;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; ANIMAL; BRAIN NEOPLASMS; DIAGNOSTIC USE; GLIOMA; HUMAN; BRAIN TUMOR;

ANIMALS; ANTIBODIES; BRAIN NEOPLASMS; GLIOMA; HUMANS; NANOPARTICLES;

EID: 84877279066     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/351031     Document Type: Review

References (164)

1. Adamson D. C., Rasheed B. A., McLendon R. E., Bigner D. D., Central nervous system. Cancer Biomarkers 2011 9 1-6 193 210 10.3233/CBM-2011-0177
2. National Cancer Institute, Central Brain Tumor Registry of the United States 2011
3. Allard E., Passirani C., Benoit J. P., Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials 2009 30 12 2302 2318 2-s2.0-60849128839 10.1016/j.biomaterials.2009.01.003
4. Stupp R., Hegi M. E., Gilbert M. R., Chakravarti A., Chemoradiotherapy in malignant glioma: standard of care and future directions. Journal of Clinical Oncology 2007 25 26 4127 4136 2-s2.0-34748884398 10.1200/JCO.2007.11.8554 (Pubitemid 47492957)
5. Parney I. F., Chang S. M., Current chemotherapy for glioblastoma. Cancer Journal 2003 9 3 149 156 2-s2.0-0642274801 10.1097/00130404-200305000-00003
6. Reardon D. A., Desjardins A., Peters K. B., Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. Cancer 2011 117 23 5351 5358 10.1002/cncr.26188
7. Stupp R., Hegi M. E., Mason W. P., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology 2009 10 5 459 466 10.1016/S1470-2045(09)70025-7
8. Lynch I., Dawson K. A., Linse S., Detecting cryptic epitopes created by nanoparticles. Science's STKE 2006 2006 327 pe14 2-s2.0-33646183969 10.1126/stke.3272006pe14
9. Colvin V. L., The potential environmental impact of engineered nanomaterials. Nature Biotechnology 2003 21 10 1166 1170 2-s2.0-0141594997 10.1038/nbt875 (Pubitemid 37203347)
10. 2 and ZnO water suspensions. Water Research 2006 40 19 3527 3532 2-s2.0-33749514962 10.1016/j.watres.2006.08.004 (Pubitemid 44527981)
11. Leary S. P., Liu C. Y., Apuzzo M. L. J., Toward the emergence of nanoneurosurgery: Part II-Nanomedicine: diagnostics and imaging at the nanoscale level. Neurosurgery 2006 58 5 805 822 2-s2.0-33646825192 10.1227/01.NEU. 0000216793.45952.ED
12. McCarthy J. R., Weissleder R., Multifunctional magnetic nanoparticles for targeted imaging and therapy. Advanced Drug Delivery Reviews 2008 60 11 1241 1251 2-s2.0-46749132642 10.1016/j.addr.2008.03.014
13. Gambhir S. S., Molecular imaging of cancer with positron emission tomography. Nature Reviews Cancer 2002 2 9 683 693 2-s2.0-0036717382 10.1038/nrc882 (Pubitemid 37328919)
14. Weber W. A., Use of PET for monitoring cancer therapy and for predicting outcome. Journal of Nuclear Medicine 2005 46 6 983 995 2-s2.0-23044447941 (Pubitemid 43733514)
15. 18F]fluoropropyl)homocysteine. Molecular Imaging and Contrast Agent Database (MICAD) 2004-2013 Bethesda, Md, USA National Library of Medicine, NIH
16. Bénard F., Romsa J., Hustinx R., Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Seminars in Nuclear Medicine 2003 33 2 148 162 2-s2.0-17744410598 10.1053/snuc.2003.127304 (Pubitemid 36577057)
17. Takeda A., Tamano H., Oku N., Alteration of zinc concentrations in the brain implanted with C6 glioma. Brain Research 2003 965 1-2 170 173 2-s2.0-0037424308 10.1016/S0006-8993(02)04165-3 (Pubitemid 36183699)
18. Liu L., Ni F., Zhang J., Jiang X., Lu X., Guo Z., Xu R., Silver nanocrystals sensitize magnetic-nanoparticle-mediated thermo-induced killing of cancer cells. Acta Biochimica et Biophysica Sinica 2011 43 4 316 323 2-s2.0-79953195578 10.1093/abbs/gmr015
19. Stippich C., Presurgical functional magnetic resonance imaging. Radiologe 2010 50 2 110 122 2-s2.0-77952806571 10.1007/s00117-009-1893-0
20. Cunningham C. H., Arai T., Yang P. C., McConnell M. V., Pauly J. M., Conolly S. M., Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magnetic Resonance in Medicine 2005 53 5 999 1005 2-s2.0-18244402192 10.1002/mrm.20477 (Pubitemid 40627773)
21. Balchandani P., Yamada M., Pauly J., Yang P., Spielman D., Self-refocused spatial-spectral pulse for positive contrast imaging of cells labeled with SPIO nanoparticles. Magnetic Resonance in Medicine 2009 62 1 183 192 2-s2.0-67650091979 10.1002/mrm.21973
22. Maeda H., Bharate G. Y., Daruwalla J., Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. European Journal of Pharmaceutics and Biopharmaceutics 2009 71 3 409 419 2-s2.0-60749108001 10.1016/j.ejpb.2008.11.010
23. Pannu H. K., Cohade C., Bristow R. E., Fishman E. K., Wahl R. L., PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation. Abdominal Imaging 2004 29 3 398 403 2-s2.0-2342620155 (Pubitemid 38590822)
24. Ruf J., Hänninen E. L., Oettle H., Plotkin M., Pelzer U., Stroszczynski C., Felix R., Amthauer H., Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI. Pancreatology 2005 5 2-3 266 272 2-s2.0-19944377522 10.1159/000085281 (Pubitemid 40754748)
25. Myers R., The application of PET-MR image registration in the brain. British Journal of Radiology 2002 75 S31 S35 2-s2.0-0036452528 (Pubitemid 35446445)
26. Čížek J., Herholz K., Vollmar S., Schrader R., Klein J., Heiss W. D., Fast and robust registration of PET and MR images of human brain. NeuroImage 2004 22 1 434 442 2-s2.0-18144447332 10.1016/j.neuroimage. 2004.01.016 (Pubitemid 38515852)
27. Huang R., Han L., Li J., Liu S., Shao K., Kuang Y., Hu X., Wang X., Lei H., Jiang C., Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis. Biomaterials 2011 32 22 5177 5186 2-s2.0-79956128895 10.1016/j.biomaterials.2011.03.075
28. Veiseh O., Kievit F. M., Fang C., Mu N., Jana S., Leung M. C., Mok H., Ellenbogen R. G., Park J. O., Zhang M., Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials 2010 31 31 8032 8042 2-s2.0-77956011432 10.1016/j.biomaterials.2010.07.016
29. Chertok B., Moffat B. A., David A. E., Yu F., Bergemann C., Ross B. D., Yang V. C., Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008 29 4 487 496 2-s2.0-36048943923 10.1016/j.biomaterials.2007.08.050 (Pubitemid 350100794)
30. Knollmann F. D., Böck J. C., Rautenberg K., Beier J., Ebert W., Felix R., Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography: preliminary results of an animal study original investigation. Investigative Radiology 1998 33 9 637 643 2-s2.0-0342699623 10.1097/00004424-199809000-00019 (Pubitemid 30261961)
31. Temming K., Schiffelers R. M., Molema G., Kok R. J., RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resistance Updates 2005 8 6 381 402 2-s2.0-33644827912 10.1016/j.drup.2005.10.002 (Pubitemid 43358061)
32. Li Z., Zhang G., Shen H., Zhang L., Wang Y., Synthesis and cell uptake of a novel dualmodality 188Re-HGRGD (D) F-CdTe QDs probe. Talanta 2011 85 2 936 942 2-s2.0-79959957528 10.1016/j.talanta.2011.04.077
33. Cai W., Rao J., Gambhir S. S., Chen X., How molecular imaging is speeding up antiangiogenic drug development. Molecular Cancer Therapeutics 2006 5 11 2624 2633 2-s2.0-33845197734 10.1158/1535-7163.MCT-06-0395 (Pubitemid 44848989)
34. Lee H. Y., Li Z., Chen K., Hsu A. R., Xu C., Xie J., Sun S., Chen X., PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. Journal of Nuclear Medicine 2008 49 8 1371 1379 2-s2.0-48749104610 10.2967/jnumed.108.051243
35. Rosca E. V., Gillies R. J., Caplan M. R., Glioblastoma targeting via integrins is concentration dependent. Biotechnology and Bioengineering 2009 104 2 408 417 2-s2.0-70349338905 10.1002/bit.22424
36. Bjornerud A., Wendland M. F., Johansson L., Ahlstrom H. K., Higgins C. B., Øksendal A., Use of intravascular contrast agents in MRI. Academic Radiology 1998 5 supplement 1 S223 S225 10.1016/S1076-6332(98)80111-6
37. Wang Y. X. J., Hussain S. M., Krestin G. P., Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. European Radiology 2001 11 11 2319 2331 2-s2.0-0034753215 10.1007/s003300100908 (Pubitemid 33041104)
38. Gossuin Y., Gillis P., Hocq A., Vuong Q. L., Roch A., Magnetic resonance relaxation properties of superparamagnetic particles. Wiley Interdisciplinary Reviews 2009 1 3 299 310 2-s2.0-77949332194 10.1002/wnan.36
39. Anzai Y., Piccoli C. W., Outwater E. K., Stanford W., Bluemke D. A., Nurenberg P., Saini S., Maravilla K. R., Feldman D. E., Schmiedl U. P., Brunberg J. A., Francis I. R., Harms S. E., Som P. M., Tempany C. M., Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: Phase III safety and efficacy study. Radiology 2003 228 3 777 788 2-s2.0-0042932291 10.1148/radiol.2283020872 (Pubitemid 37025489)
40. Shubayev V. I., Pisanic T. R. II, Jin S., Magnetic nanoparticles for theragnostics. Advanced Drug Delivery Reviews 2009 61 6 467 477 2-s2.0-65649115808 10.1016/j.addr.2009.03.007
41. Thorek D. L. J., Chen A. K., Czupryna J., Tsourkas A., Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Annals of Biomedical Engineering 2006 34 1 23 38 2-s2.0-33645214569 10.1007/s10439-005-9002-7
42. Gultepe E., Reynoso F. J., Jhaveri A., Kulkarni P., Nagesha D., Ferris C., Harisinghani M., Campbell R. B., Sridhar S., Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine 2010 5 8 1173 1182 2-s2.0-78149287643 10.2217/nnm.10.84
43. Winter P. M., Morawski A. M., Caruthers S. D., Fuhrhop R. W., Zhang H., Williams T. A., Allen J. S., Lacy E. K., Robertson J. D., Lanza G. M., Wickline S. A., Molecular imaging of angiogenesis in early-stage atherosclerosis with α v β 3-integrin-targeted nanoparticles. Circulation 2003 108 18 2270 2274 2-s2.0-0242266976 10.1161/01.CIR.0000093185.16083.95 (Pubitemid 37363046)
44. Montet X., Montet-Abou K., Reynolds F., Weissleder R., Josephson L., Nanoparticle imaging of integrins on tumor cells. Neoplasia 2006 8 3 214 222 2-s2.0-33646350286 10.1593/neo.05769 (Pubitemid 43671237)
45. Nahrendorf M., Jaffer F. A., Kelly K. A., Sosnovik D. E., Aikawa E., Libby P., Weissleder R., Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006 114 14 1504 1511 2-s2.0-33749534329 10.1161/CIRCULATIONAHA.106.646380 (Pubitemid 44527006)
46. Lee J. H., Huh Y.-M., Jun Y.-W., Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nature Medicine 2007 13 1 95 99 10.1038/nm1467 (Pubitemid 46067392)
47. Di Marco M., Sadun C., Port M., Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. International Journal of Nanomedicine 2007 2 4 609 622
48. Egelhof T., Delbeck N., Hartmann M., Can superparamagnetic contrast media improve MRI-tomographic images of experimental gliomas? Radiologe 1998 38 11 943 947
49. Enochs W. S., Harsh G., Hochberg F., Weissleder R., Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. Journal of Magnetic Resonance Imaging 1999 9 2 228 232 (Pubitemid 29115346)
50. Knauth M., Egelhof T., Roth S. U., Wirtz C. R., Sartor K., Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. American Journal of Neuroradiology 2001 22 1 99 102 2-s2.0-0035141747 (Pubitemid 32105361)
51. Huang J., Xie J., Chen K., Bu L., Lee S., Cheng Z., Li X., Chen X., HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chemical Communications 2010 46 36 6684 6686 2-s2.0-77956337298 10.1039/c0cc01041c
52. Bennewitz M. F., Lobo T. L., Nkansah M. K., Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011 5 5 3438 3446 10.1021/nn1019779
53. Faucher L., Faucher L., Guay-Bégin A. A., Lagueux J., Côté M. F., Petitclerc E., Fortin M. A., Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media & Molecular Imaging 2011 6 4 209 218
54. Robson M. D., Bydder G. M., Clinical ultrashort echo time imaging of bone and other connective tissues. NMR in Biomedicine 2006 19 7 765 780 2-s2.0-33751368661 10.1002/nbm.1100 (Pubitemid 44811542)
55. Rahmer J., Börnert P., Dries S. P. M., Assessment of anterior cruciate ligament reconstruction using 3D ultrashort echo-time MR imaging. Journal of Magnetic Resonance Imaging 2009 29 2 443 448 2-s2.0-60549089990 10.1002/jmri.21653
56. Chen X., Hou Y., Tohme M., Park R., Khankaldyyan V., Gonzales-Gomez I., Bading J. R., Laug W. E., Conti P. S., Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor α v β 3-integrin expression. Journal of Nuclear Medicine 2004 45 10 1776 1783 2-s2.0-13944263708 (Pubitemid 47618490)
57. Jia B., Shi J., Yang Z., Xu B., Liu Z., Zhao H., Liu S., Wang F., 99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin α v β 3 expression. Bioconjugate Chemistry 2006 17 4 1069 1076 2-s2.0-33746775329 10.1021/bc060055b (Pubitemid 44162628)
58. Cruet S., Salamanca C., Mitchell G. W. E., Auersperg N., α v β 3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation. Gynecologic Oncology 1999 75 2 254 260 2-s2.0-0032586285 10.1006/gyno.1999.5572 (Pubitemid 29523029)
59. Dijkgraaf I., Kruijtzer J. A. W., Frielink C., Corstens F. H. M., Oyen W. J. G., Liskamp R. M. J., Boerman O. C., α v β 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide. International Journal of Cancer 2007 120 3 605 610 2-s2.0-33845697526 10.1002/ijc.22297 (Pubitemid 44969032)
60. Zhang L., Zhong X., Wang L., Chen H., Wang Y. A., Yeh J., Yang L., Mao H., T1-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles. Journal of Magnetic Resonance Imaging 2011 33 1 194 202 2-s2.0-78650676149 10.1002/jmri.22412
61. Hirsch L. R., Gobin A. M., Lowery A. R., Metal nanoshells. Annals of Biomedical Engineering 2006 34 1 15 22 10.1007/s10439-005-9001-8
62. Loo C., Hirsch L., Lee M. H., Chang E., West J., Halas N., Drezek R., Gold nanoshell bioconjugates for molecular imaging in living cells. Optics Letters 2005 30 9 1012 1014 2-s2.0-19944411827 10.1364/OL.30.001012 (Pubitemid 40749266)
63. West J. L., Halas N. J., Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Annual Review of Biomedical Engineering 2003 5 285 292 2-s2.0-0642366760 10.1146/annurev.bioeng. 5.011303.120723 (Pubitemid 40125314)
64. Lin A. W. H., Lewinski N. A., West J. L., Halas N. J., Drezek R. A., Optically tunable nanoparticle contrast agents for early cancer detection: model-based analysis of gold nanoshells. Journal of Biomedical Optics 2005 10 6 2-s2.0-33644769454 10.1117/1.2141825 064035 (Pubitemid 44255987)
65. Talley C. E., Jackson J. B., Oubre C., Grady N. K., Hollars C. W., Lane S. M., Huser T. R., Nordlander P., Halas N. J., Surface-enhanced Raman scattering from individual Au nanoparticles and nanoparticle dimer substrates. Nano Letters 2005 5 8 1569 1574 2-s2.0-24344504071 10.1021/nl050928v (Pubitemid 41251691)
66. Gheorghe D. E., Cui L., Karmonik C., Gold-silver alloy nanoshells: a new candidate for nanotherapeutics and diagnostics. Nanoscale Research Letters 2011 6, article 554 10.1186/1556-276X-6-554
67. Lowery A. R., Gobin A. M., Day E. S., Halas N. J., West J. L., Immunonanoshells for targeted photothermal ablation of tumor cells. International Journal of Nanomedicine 2006 1 2 149 154 2-s2.0-34548620551 10.2147/nano.2006.1.2.149
68. Naczynski D. J., Andelman T., Pal D., Chen S., Riman R. E., Roth C. M., Moghe P. V., Albumin nanoshell encapsulation of near-infrared-excitable rare-earth nanoparticles enhances biocompatibility and enables targeted cell imaging. Small 2010 6 15 1631 1640 2-s2.0-77955212868 10.1002/smll.200902403
69. Cai W., Shin D. W., Chen K., Gheysens O., Cao Q., Wang S. X., Gambhir S. S., Chen X., Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Letters 2006 6 4 669 676 2-s2.0-33646394346 10.1021/nl052405t
70. Reiss P., Protière M., Li L., Core/shell semiconductor nanocrystals. Small 2009 5 2 154 168 2-s2.0-59449084678 10.1002/smll.200800841
71. Arya H., Kaul Z., Wadhwa R., Taira K., Hirano T., Kaul S. C., Quantum dots in bio-imaging: revolution by the small. Biochemical and Biophysical Research Communications 2005 329 4 1173 1177 2-s2.0-17644411099 10.1016/j.bbrc.2005.02.043 (Pubitemid 40568694)
72. Smith A. M., Duan H., Mohs A. M., Nie S., Bioconjugated quantum dots for in vivo molecular and cellular imaging. Advanced Drug Delivery Reviews 2008 60 11 1226 1240 2-s2.0-46749091612 10.1016/j.addr.2008.03.015
73. Popescu M. A., Toms S. A., In vivo optical imaging using quantum dots for the management of brain tumors. Expert Review of Molecular Diagnostics 2006 6 6 879 890 2-s2.0-33845414964 10.1586/14737159.6.6.879 (Pubitemid 44904004)
74. Jackson H., Muhammad O., Daneshvar H., Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas. Neurosurgery 2007 60 3 524 530 2-s2.0-33847394921 10.1227/01.NEU.0000255334.95532.DD
75. Kim S., Lim Y. T., Soltesz E. G., De Grand A. M., Lee J., Nakayama A., Parker J. A., Mihaljevic T., Laurence R. G., Dor D. M., Cohn L. H., Bawendi M. G., Frangioni J. V., Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nature Biotechnology 2004 22 1 93 97 2-s2.0-0347473808 10.1038/nbt920 (Pubitemid 38057962)
76. Morgan N. Y., English S., Chen W., Chernomordik V., Russo A., Smith P. D., Gandjbakhche A., Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots. Academic Radiology 2005 12 3 313 323 2-s2.0-14844340625 10.1016/j.acra.2004.04.023 (Pubitemid 40353762)
77. Wang Y., Ye C., Wu L., Hu Y., Synthesis and characterization of self-assembled CdHgTe/gelatin nanospheres as stable near infrared fluorescent probes in vivo. Journal of Pharmaceutical and Biomedical Analysis 2010 53 3 235 242 2-s2.0-77954863432 10.1016/j.jpba.2010.02.028
78. Wang H. J., Yang L., Yang H. Y., Wang K., Yao W. G., Jiang K., Huang X. L., Zheng Z., Antineoplastic activities of protein-conjugated silver sulfide nano-crystals with different shapes. Journal of Inorganic Biochemistry 2010 104 1 87 91 2-s2.0-70449656812 10.1016/j.jinorgbio.2009.10.015
79. Banchereau J., Palucka A. K., Dendritic cells as therapeutic vaccines against cancer. Nature Reviews Immunology 2005 5 4 296 306 2-s2.0-17144417748 10.1038/nri1592 (Pubitemid 40516155)
80. Klippstein R., Pozo D., Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine 2010 6 4 523 529 2-s2.0-77955270464 10.1016/j.nano.2010.01.001
81. Adams G. P., Weiner L. M., Monoclonal antibody therapy of cancer. Nature Biotechnology 2005 23 9 1147 1157 2-s2.0-27144449009 10.1038/nbt1137 (Pubitemid 41486396)
82. Schrama D., Reisfeld R. A., Becker J. C., Antibody targeted drugs as cancer therapeutics. Nature Reviews Drug Discovery 2006 5 2 147 159 2-s2.0-33645056478 10.1038/nrd1957
83. Papahadjopoulos D., Portis A., Pangborn W., Calcium induced lipid phase transitions and membrane fusion. Annals of the New York Academy of Sciences 1978 308 50 66 2-s2.0-0018198851 (Pubitemid 8372517)
84. Ryman B. E., Jewkes R. F., Jeyasingh K., Potential application of liposomes to therapy. Annals of the New York Academy of Sciences 1978 308 281 307 2-s2.0-0017902846 (Pubitemid 8372535)
85. Lasic D. D., Frederik P. M., Stuart M. C. A., Barenholz Y., McIntosh T. J., Gelation of liposome interior. A novel method for drug encapsulation. FEBS Letters 1992 312 2-3 255 258 2-s2.0-0026453662 10.1016/0014-5793(92)80947-F
86. Bangham A. D., Surrogate cells or Trojan horses. The discovery of liposomes. BioEssays 1995 17 12 1081 1088 2-s2.0-0029444559
87. Chen H., Qina Y., Zhang Q., Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. European Journal of Pharmaceutical Sciences 2011 44 1-2 164 173 10.1016/j.ejps.2011.07.007
88. Qin Y., Chena H., Zhang Q., Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. International Journal of Pharmaceutics 2011 420 2 304 312 10.1016/j.ijpharm.2011.09.008
89. Gong W., Wang Z., Liu N., Lin W., Wang X., Xu D., Liu H., Zeng C., Xie X., Mei X., Lü W., Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia. Biological and Pharmaceutical Bulletin 2011 34 7 1058 1064 2-s2.0-79960320339 10.1248/bpb.34.1058
90. Fellner S., Bauer B., Miller D. S., Schaffrik M., Fankhänel M., Spruß T., Bernhardt G., Graeff C., Färber L., Gschaidmeier H., Buschauer A., Fricker G., Transport of paclitaxel (taxol) across the blood-brain barrier in vitro and in vivo. Journal of Clinical Investigation 2002 110 9 1309 1318 2-s2.0-0036841686 10.1172/JCI200215451 (Pubitemid 35285757)
91. Xin H., Jiang X., Gu J., Sha X., Chen L., Law K., Chen Y., Wang X., Jiang Y., Fang X., Angiopep-conjugated poly(ethylene glycol)-co-poly(ε -caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 2011 32 18 4293 4305 2-s2.0-79955104821 10.1016/j.biomaterials.2011.02.044
92. Wang J., Liu W., Tu Q., Wang J., Song N., Zhang Y., Nie N., Wang J., Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules 2011 12 1 228 234 2-s2.0-78651289585 10.1021/bm101206g
93. Hatcher H., Planalp R., Cho J., Torti F. M., Torti S. V., Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Sciences 2008 65 11 1631 1652 2-s2.0-44749093175 10.1007/s00018-008-7452-4
94. Aggarwal B. B., Kumar A., Bharti A. C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research 2003 23 1 363 398 2-s2.0-0037236792 (Pubitemid 36361976)
95. Maheshwari R. K., Singh A. K., Gaddipati J., Srimal R. C., Multiple biological activities of curcumin: a short review. Life Sciences 2006 78 18 2081 2087 2-s2.0-33644901007 10.1016/j.lfs.2005.12.007
96. Kunnumakkara A. B., Anand P., Aggarwal B. B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Letters 2008 269 2 199 225 2-s2.0-51349137454 10.1016/j.canlet.2008.03.009
97. Ravindran J., Prasad S., Aggarwal B. B., Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS Journal 2009 11 3 495 510 2-s2.0-73349094986 10.1208/s12248-009-9128-x
98. Atkinson G. P., Nozell S. E., Benveniste E. N., NF- B and STAT3 signaling in glioma: targets for future therapies. Expert Review of Neurotherapeutics 2010 10 4 575 586 2-s2.0-77953633109 10.1586/ern.10.21
99. Schmidt A. L., Brunetto A. L., Schwartsmann G., Roesler R., Abujamra A. L., Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets. CNS and Neurological Disorders 2010 9 3 335 348 2-s2.0-77954341523
100. Lim K. J., Bisht S., Bar E. E., Maitra A., Eberhart C. G., A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biology and Therapy 2011 11 5 464 473 2-s2.0-79952341098 10.4161/cbt.11.5.14410
101. Shao J., Zheng D., Jiang Z., Xu H., Hu Y., Li X., Lu X., Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells. Acta Biochimica et Biophysica Sinica 2011 43 4 267 274 2-s2.0-79953224514 10.1093/abbs/gmr011
102. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., DuBois R. N., Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998 93 5 705 716 2-s2.0-0003504049 10.1016/S0092-8674(00)81433-6 (Pubitemid 28257578)
103. Kim T. H., Jeong Y. I., Jin S. G., Preparation of polylactide-co- glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells. International Journal of Nanomedicine 2011 6 2621 2631
104. Primeau A. J., Rendon A., Hedley D., Lilge L., Tannock I. F., The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clinical Cancer Research 2005 11 24, part 1 8782 8788 2-s2.0-29344443251 10.1158/1078-0432.CCR-05-1664 (Pubitemid 43005929)
105. Siegal T., Horowitz A., Gabizon A., Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. Journal of Neurosurgery 1995 83 6 1029 1037 2-s2.0-0029585915 (Pubitemid 26048143)
106. Gabizon A., Martin F., Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 1997 54 supplement 4 15 21 2-s2.0-0030669086 (Pubitemid 27487791)
107. Kateb B., Van Handel M., Zhang L., Bronikowski M. J., Manohara H., Badie B., Internalization of MWCNTs by microglia: possible application in immunotherapy of brain tumors. NeuroImage 2007 37 supplement 1 S9 S17 2-s2.0-34547752544 10.1016/j.neuroimage.2007.03.078 (Pubitemid 47239427)
108. Vyas S. P., Singh A., Sihorkar V., Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Critical Reviews in Therapeutic Drug Carrier Systems 2001 18 1 1 76 2-s2.0-0035053829 (Pubitemid 32319397)
109. Qian Z. M., Li H., Sun H., Ho K., Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacological Reviews 2002 54 4 561 587 2-s2.0-0036889760 10.1124/pr.54.4.561 (Pubitemid 35351196)
110. Kito A., Yoshida J., Kageyama N., Kojima N., Yagi K., Liposomes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma. Journal of Neurosurgery 1989 71 3 382 387 2-s2.0-0024325808 (Pubitemid 19225551)
111. Eavarone D. A., Yu X., Bellamkonda R. V., Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. Journal of Biomedical Materials Research 2000 51 1 10 14 (Pubitemid 30331976)
112. Chan W. C. W., Nie S., Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998 281 5385 2016 2018 2-s2.0-0032566763 10.1126/science.281.5385.2016 (Pubitemid 28475486)
113. Dubertret B., Skourides P., Norris D. J., Noireaux V., Brivanlou A. H., Libchaber A., In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002 298 5599 1759 1762 2-s2.0-2242495402 10.1126/science. 1077194 (Pubitemid 35404113)
114. Gao X., Cui Y., Levenson R. M., Chung L. W. K., Nie S., In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnology 2004 22 8 969 976 2-s2.0-3543022686 10.1038/nbt994 (Pubitemid 39014473)
115. Xiang Y., Liang L., Wang X., Wang J., Zhang X., Zhang Q., Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Journal of Controlled Release 2011 152 3 402 410 2-s2.0-79958231722 10.1016/j.jconrel.2011.03.014
116. Vallhov H., Gabrielsson S., Strømme M., Scheynius A., Garcia-Bennett A. E., Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Letters 2007 7 12 3576 3582 2-s2.0-38049161380 10.1021/nl0714785
117. Ahamed M., AlSalhi M. S., Siddiqui M. K. J., Silver nanoparticle applications and human health. Clinica Chimica Acta 2010 411 23-24 1841 1848 2-s2.0-77957753618 10.1016/j.cca.2010.08.016
118. AshaRani P. V., Mun G. L. K., Hande M. P., Valiyaveettil S., Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009 3 2 279 290 2-s2.0-63449105617 10.1021/nn800596w
119. Kim S., Choi J. E., Choi J., Chung K. H., Park K., Yi J., Ryu D. Y., Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicology in Vitro 2009 23 6 1076 1084 2-s2.0-68049090816 10.1016/j.tiv.2009.06.001
120. Carlson C., Hussein S. M., Schrand A. M., Braydich-Stolle L. K., Hess K. L., Jones R. L., Schlager J. J., Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. Journal of Physical Chemistry B 2008 112 43 13608 13619 2-s2.0-55949113520 10.1021/jp712087m
121. Asharani P. V., Xinyi N., Hande M. P., Valiyaveettil S., DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine 2010 5 1 51 64 2-s2.0-75949131173 10.2217/nnm.09.85
122. Yang L., Wang H. J., Yang H. Y., Liu S. H., Zhang B. F., Wang K., Ma X. M., Zheng Z., Shape-controlled synthesis of protein-conjugated silver sulfide nanocrystals and study on the inhibition of tumor cell viability. Chemical Communications 2008 26 2995 2997 2-s2.0-46149116820 10.1039/b804274h (Pubitemid 351904571)
123. Levard C., Hotze E. M., Lowry G. V., Brown G. E. Jr., Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environmental Science & Technology 2012 46 13 6900 6914 10.1021/es2037405
124. Li J. J., Zhu K. D., Spin-based optomechanics with carbon nanotubes. Scientific Reports 2012 2, article 903
125. Meziani M. J., Sun Y. P., Protein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solution. Journal of the American Chemical Society 2003 125 26 8015 8018 2-s2.0-0038540641 10.1021/ja030104k (Pubitemid 36782179)
126. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M. L. H., Sim R. B., Complement activation and protein adsorption by carbon nanotubes. Molecular Immunology 2006 43 3 193 201 2-s2.0-25644454502 10.1016/j.molimm.2005.02.006 (Pubitemid 41384125)
127. Klumpp C., Kostarelos K., Prato M., Bianco A., Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochimica et Biophysica Acta 2006 1758 3 404 412 2-s2.0-33646534455 10.1016/j.bbamem.2005. 10.008
128. Kresge C. T., Leonowicz M. E., Roth W. J., Vartuli J. C., Beck J. S., Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992 359 6397 710 712 2-s2.0-0026931265 (Pubitemid 23589384)
129. Asefa T., MacLachlan M. J., Coombs N., Ozin G. A., Periodic mesoporous organosilicas with organic groups inside the channel walls. Nature 1999 402 6764 867 871 2-s2.0-0033599035 10.1038/47229 (Pubitemid 30017166)
130. Tian Z. R., Tong W., Wang J. Y., Duan N. G., Krishnan V. V., Suib S. L., Manganese oxide mesoporous structures: mixed-valent semiconducting catalysts. Science 1997 276 5314 926 930 2-s2.0-0031560768 10.1126/science.276.5314.926 (Pubitemid 27209085)
131. Armatas G. S., Kanatzidis M. G., Mesostructured germanium with cubic pore symmetry. Nature 2006 441 7097 1122 1125 2-s2.0-33745614305 10.1038/nature04833 (Pubitemid 43990729)
132. 4- anion. Nature 2001 410 6829 671 675 2-s2.0-0035810181 10.1038/35070533 (Pubitemid 32290349)
133. Roy I., Mitra S., Maitra A., Mozumdar S., Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. International Journal of Pharmaceutics 2003 250 1 25 33 2-s2.0-0037413362 10.1016/S0378-5173(02)00452-0 (Pubitemid 35447934)
134. Wu S. H., Mou C. Y., Lin H. P., Synthesis of mesoporous silica nanoparticles. Chemical Society Reviews 2013 10.1039/C3CS35405A
135. Dhanikula R. S., Argaw A., Bouchard J. F., Hildgen P., Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Molecular Pharmaceutics 2008 5 1 105 116 2-s2.0-39749200864 10.1021/mp700086j (Pubitemid 351300040)
136. Ren Y., Kang C. S., Yuan X. B., Zhou X., Xu P., Han L., Wang G. X., Jia Z., Zhong Y., Yu S., Sheng J., Pu P. Y., Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. Journal of Biomaterials Science 2010 21 3 303 314 2-s2.0-77749279909 10.1163/156856209X415828
137. Tan M., Wu X., Jeong E. K., Chen Q., Lu Z. R., Peptide-targeted nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging. Biomacromolecules 2010 11 3 754 761 2-s2.0-77950170337 10.1021/bm901352v
138. Wiener E. C., Brechbiel M. W., Brothers H., Magin R. L., Gansow O. A., Tomalia D. A., Lauterbur P. C., Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magnetic Resonance in Medicine 1994 31 1 1 8 2-s2.0-0027957863 10.1002/mrm.1910310102 (Pubitemid 24016935)
139. Cheng Z., Thorek D. L. J., Tsourkas A., Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T 1 magnetic resonance imaging contrast agent. Angewandte Chemie 2010 49 2 346 350 2-s2.0-73349083082 10.1002/anie.200905133
140. Lee C. C., MacKay J. A., Fréchet J. M. J., Szoka F. C., Designing dendrimers for biological applications. Nature Biotechnology 2005 23 12 1517 1526 10.1038/nbt1171 (Pubitemid 41752929)
141. Tang M. X., Redemann C. T., Szoka F. C. Jr., In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chemistry 1996 7 6 703 714 2-s2.0-0030293017 10.1021/bc9600630 (Pubitemid 27012712)
142. Yan H., Wang J., Yi P., Lei H., Zhan C., Xie C., Feng L., Qian J., Zhu J., Lu W., Li C., Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier. Chemical Communications 2011 47 28 8130 8132 2-s2.0-79959903861 10.1039/c1cc12007g
143. Pulfer S. K., Ciccotto S. L., Gallo J. M., Distribution of small magnetic particles in brain tumor-bearing rats. Journal of Neuro-Oncology 1999 41 2 99 105 2-s2.0-0032903576 10.1023/A:1006137523591 (Pubitemid 29161004)
144. Zhang T., Herlyn D., Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer. Cancer Immunology, Immunotherapy 2009 58 4 475 492 2-s2.0-59449090966 10.1007/s00262-008-0598-y
145. Kreuter J., Gelperina S., Use of nanoparticles for cerebral cancer. Tumori 2008 94 2 271 277 2-s2.0-45249092544 (Pubitemid 351838835)
146. Pozo D., Immune-based disorders: the challenges for translational immunology. Journal of Cellular and Molecular Medicine 2008 12 4 1085 1086 2-s2.0-49549122250 10.1111/j.1582-4934.2008.00349.x
147. Fujita M., Lee B. S., Khazenzon N. M., Penichet M. L., Wawrowsky K. A., Patil R., Ding H., Holler E., Black K. L., Ljubimova J. Y., Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(β -l-malic acid). Journal of Controlled Release 2007 122 3 356 363 2-s2.0-34548697576 10.1016/j.jconrel.2007.05.032 (Pubitemid 47411593)
148. Ljubimova J. Y., Fujita M., Khazenzon N. M., Lee B. S., Wachsmann-Hogiu S., Farkas D. L., Black K. L., Holler E., Nanoconjugate based on polymalic acid for tumor targeting. Chemico-Biological Interactions 2008 171 2 195 203 2-s2.0-38349148359 10.1016/j.cbi.2007.01.015
149. Gasslmaier B., Krell C. M., Seebach D., Holler E., Synthetic substrates and inhibitors of β -poly(L-malate)-hydrolase (polymalatase). European Journal of Biochemistry 2000 267 16 5101 5105 2-s2.0-0033884825 10.1046/j.1432-1327.2000.01573.x (Pubitemid 30641305)
150. Cammas S., Béar M. M., Moine L., Escalup R., Ponchel G., Kataoka K., Guérin P., Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices. International Journal of Biological Macromolecules 1999 25 1-3 273 282 2-s2.0-0345711678 10.1016/S0141-8130(99)00042-2 (Pubitemid 29302007)
151. Zhang L., Yao J., Zhou J., Wang T., Zhang Q., Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs. International Journal of Pharmaceutics 2013 441 1-2 654 664 10.1016/j.ijpharm.2012.10.030
152. Lee B. S., Vert M., Holler E., Doi Y., Steinbuchel A., Water-soluble Aliphatic Polyesters: poly(malic acid)s. Biopolymers 2002 3 New York, NY, USA Wiley-VCH 75 103
153. Zhang Y., Pardridge W. M., Delivery of β -galactosidase to mouse brain via the blood-brain barrier transferrin receptor. Journal of Pharmacology and Experimental Therapeutics 2005 313 3 1075 1081 2-s2.0-19444381236 10.1124/jpet.104.082974 (Pubitemid 40727011)
154. Bickel U., Yoshikawa T., Pardridge W. M., Delivery of peptides and proteins through the blood-brain barrier. Advanced Drug Delivery Reviews 2001 46 1-3 247 279 2-s2.0-0035292828 10.1016/S0169-409X(00)00139-3
155. Torchilin V. P., Lukyanov A. N., Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discovery Today 2003 8 6 259 266 2-s2.0-0037443713 10.1016/S1359-6446(03)02623-0 (Pubitemid 36293499)
156. Lakoubov L. Z., Torchilin V. P., A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ana) from healthy aged nonautoimmune mice. Oncology Research 1997 9 8 439 446 2-s2.0-0031308829 (Pubitemid 127825997)
157. Feng B., Tomizawa K., Michiue H., Miyatake S. I., Han X. J., Fujimura A., Seno M., Kirihata M., Matsui H., Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His. Biomaterials 2009 30 9 1746 1755 2-s2.0-58849127706 10.1016/j.biomaterials.2008. 12.010
158. Müller R. H., Mäder K., Gohla S., Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 161 177 2-s2.0-0038032150 10.1016/S0939-6411(00)00087-4 (Pubitemid 30326695)
159. Kuo Y. C., Liang C. T., Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 2011 32 12 3340 3350 2-s2.0-79951770196 10.1016/j.biomaterials.2011.01.048
160. Kuo Y. C., Liang C. T., Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells. Colloids and Surfaces B 2011 85 2 131 137 2-s2.0-79955646431 10.1016/j.colsurfb.2011.02.011
161. Shokeen M., Pressly E. D., Hagooly A., Zheleznyak A., Ramos N., Fiamengo A. L., Welch M. J., Hawker C. J., Anderson C. J., Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano 2011 5 2 738 747 2-s2.0-79951904994 10.1021/nn102278w
162. Kohane D. S., Microparticles and nanoparticles for drug delivery. Biotechnology and Bioengineering 2007 96 2 203 209 2-s2.0-33846928678 10.1002/bit.21301 (Pubitemid 46232255)
163. Faraji A. H., Wipf P., Nanoparticles in cellular drug delivery. Bioorganic and Medicinal Chemistry 2009 17 8 2950 2962 2-s2.0-64049086772 10.1016/j.bmc.2009.02.043
164. Murakami H., Kobayashi M., Takeuchi H., Kawashima Y., Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. International Journal of Pharmaceutics 1999 187 2 143 152 2-s2.0-0032851413 10.1016/S0378-5173(99)00187-8 (Pubitemid 29443894)